The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples